AbioCor II

(redirected from AbioCor)
Also found in: Wikipedia.

AbioCor II

A next-generation implantable replacement heart, which incorporates the best from AbioCor and the Penn State Heart. It is smaller, and thus fits into more patients, with a goal is 5-year reliability.

References in periodicals archive ?

Doctors from the University of Louisville implanted the first self-contained artificial heart, the AbioCor, in 2001.

Scientists trying 3-D printer to build a human heart

The AbioCor self-contained, mechanical heart developed by Abiomed, of Danvers, Massachusetts.

Artificial organs raise troubling questions

Morris [5] presented the review of artificial hearts on two different makes, namely CardioWest and AbioCor with the operating principles are deliberately explained.

Axial flow artificial heart blood pumps: a brief review

The AbioCor is a completely self-contained replacement heart designed to sustain the body's circulatory system.

Timeline for the Future: Potential Developments and Likely Impacts: designer babies, fiber-optic plants, synthetic celebrities, and more. a timeline suggests when we'll see the evolving technologies that will radically reshape human life

In June 2009 Abiomed received approval from the Centers for Medicare and Medicaid Services (CMS) for reimbursement of its AbioCor Total Replacement Heart and 510(k) clearance from the FDA for its Impella 2.5 Cardiac Assist Device.

Names in the News

For instance, she alludes to, but does not offer support for, racial underpinnings in the selection of two Black men as the first recipients of the AbioCor artificial heart in 2001 and 2002.

Medical Apartheid: The Dark History of Medical Experimentation on Black Americans From Colonial Times to the Present (2006)

Swazey, "'He Knows That Machine Is His Mortality': Old and New Social and Cultural Patterns in the Clinical Trial of the AbioCor Artificial Heart," Perspectives in Biology and Medicine 47 (2004): 74-99; G.J.

The therapeutic misconception at 25: treatment, research, and confusion

However, two newly available devices present a unique challenge-Boston Scientific's Wingspan intracranial stent, approved under an HDE in August 2005, and Abiomed's Abiocor total artificial heart, granted HDE status in September.

CMS advisory committee supports humanitarian-device trial coverage

The Food and Drug Administration has given a limited approval to the first totally artificial implantable heart, Abiomed Inc.'s AbioCor.

FDA approves first artificial implantable heart

The AbioCor is the result of almost 30 years of research and development, much of which was supported by the National Heart, Lung, and Blood Institute.